Signal active
Bio
Briggs Morrison is the CEO at Syndax Pharmaceuticals. He attended Dana Farber Cancer Institute.
Location
Cambridge, Massachusetts, United States, North America
Social
Primary Organization
2005
101-250
Biotechnology, Health Care, Pharmaceutical, Clinical Trials
Jobs history
4
Auransa
Advisor
2022 - Current
Photys Therapeutics
Board of Directors
Invalid date - Current
Syndax Pharmaceuticals
President, Head of Research & Development
2022 - Current
Syndax Pharmaceuticals
Director
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Briggs Morrison is the President, Head of Research & Development at Syndax Pharmaceuticals, based in United States, North America. With a background in Biotechnology, Briggs Morrison has a rich history of leadership and innovation. Briggs Morrison studied BS Biology @ Georgetown University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
1
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Sep 08, 2022 | Photys Therapeutics | Series A - Photys Therapeutics | MPM Capital | 75.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.